OXFORD BIOSCIENCE PARTNERS IV LP Insider Trading

FREE EMAIL WATCHDOG

Get free email notifications about insider trading for OXFORD BIOSCIENCE PARTNERS IV LP.

  • Your email is safe with us.
  • The service is free and you can unsubscribe at any time.

General | Insider Transactions | Monthly Overview

Get the latest insider transactions of OXFORD BIOSCIENCE PARTNERS IV LP. OXFORD BIOSCIENCE PARTNERS IV LP is a 10% Owner in IMCOR PHARMACEUTICAL CO ($ICPH).

Address: 222 BERKELEY STREET, SUITE 1650 BOSTON 02216 MA

Companies in which OXFORD BIOSCIENCE PARTNERS IV LP is an Insider

IMCOR PHARMACEUTICAL CO

Trading Symbol: ICPH
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of OXFORD BIOSCIENCE PARTNERS IV LP: 10% Owner
Holdings: 44,564,652 shares
Latest Transaction: Feb 17 2005

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions

Latest Insider Trading Transactions of OXFORD BIOSCIENCE PARTNERS IV LP

DateTickerCompanyOwnerRelationship Transaction Code Cost ($) Shares Transaction Value ($) Total Shares % Holdings
Feb 17 2005ICPHIMCOR PHARMACEUTIC ...OXFORD BIOSCIENCE PARTNERS IV ...10% OwnerGrantA0.3549,78617,42544,564,65244.5 M to 44.6 M (+0.11 %)
Jun 17 2004ICPHIMCOR PHARMACEUTIC ...OXFORD BIOSCIENCE PARTNERS IV ...10% OwnerOption ExerciseP1.001,452,0981,452,0981,452,098
Jun 17 2004ICPHIMCOR PHARMACEUTIC ...OXFORD BIOSCIENCE PARTNERS IV ...10% OwnerSellS0.758,696,5486,522,41108.7 M to 0 (-100.00 %)
Jun 17 2004ICPHIMCOR PHARMACEUTIC ...OXFORD BIOSCIENCE PARTNERS IV ...10% OwnerSellS0.753,861,6022,896,20203.9 M to 0 (-100.00 %)
Jun 17 2004ICPHIMCOR PHARMACEUTIC ...OXFORD BIOSCIENCE PARTNERS IV ...10% OwnerBuyP0.7511,595,3978,696,54826,065,49114.5 M to 26.1 M (+80.13 %)
Jun 17 2004ICPHIMCOR PHARMACEUTIC ...OXFORD BIOSCIENCE PARTNERS IV ...10% OwnerBuyP0.755,148,8023,861,60214,470,0949.3 M to 14.5 M (+55.24 %)
Jun 17 2004ICPHIMCOR PHARMACEUTIC ...OXFORD BIOSCIENCE PARTNERS IV ...10% OwnerBuyP0.752,904,1952,178,1469,321,2926.4 M to 9.3 M (+45.26 %)

View all OXFORD BIOSCIENCE PARTNERS IV LP insider transactions.